In an experimental mouse models of breast and colon cancer, anti-PCSK9 vaccine, which led to lower plasma level and activity of PCSK9, was associated with moderate but not significant tumor growth reduction and prolongation of lifespan [210,211]. This evidence concerns the gene PCSK9 and neoplasm.